Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
Zhao L, Li W, Marshall C, Griffin T, Hanson M, Hick R, Dentchev T, Williams E, Werth A, Miller C, Bashir H, Pear W, Seykora JT.
Zhao L, et al. Among authors: li w.
Cancer Res. 2009 Dec 15;69(24):9439-47. doi: 10.1158/0008-5472.CAN-09-2976.
Cancer Res. 2009.
PMID: 19934324
Free PMC article.